The estimated Net Worth of Charles P Slacik is at least $1.4 Millón dollars as of 25 January 2022. Mr. Slacik owns over 12,086 units of QuidelOrtho stock worth over $1,079,405 and over the last 12 years he sold QDEL stock worth over $123,470. In addition, he makes $196,921 as Independent Director at QuidelOrtho.
Charles has made over 11 trades of the QuidelOrtho stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 12,086 units of QDEL stock worth $236,160 on 25 January 2022.
The largest trade he's ever made was exercising 12,086 units of QuidelOrtho stock on 25 January 2022 worth over $236,160. On average, Charles trades about 1,564 units every 100 days since 2012. As of 25 January 2022 he still owns at least 24,067 units of QuidelOrtho stock.
You can see the complete history of Mr. Slacik stock trades at the bottom of the page.
Charles P. Slacik serves as Independent Director of the Company. Mr. Slacik has more than 30 years of executive experience in the health care industry, serving most recently as the Senior Vice President and Chief Financial Officer of Beckman Coulter Inc. from October 2006 until its acquisition in June 2011. Mr. Slacik recently served as a member of the Board and Chair of the Audit Committee of STAAR Surgical Company, a medical device company, from September 2012 through September 2016 and as a Member of the Board and Chair of the Audit Committee at Sequenom, Inc., a life sciences company, from September 2012 until its acquisition in September 2016. Mr. Slacik received his B.S. in Accounting and Finance from the University of Connecticut and is a certified public accountant.
As the Independent Director of QuidelOrtho, the total compensation of Charles Slacik at QuidelOrtho is $196,921. There are 16 executives at QuidelOrtho getting paid more, with Douglas Bryant having the highest compensation of $4,168,770.
Charles Slacik is 66, he's been the Independent Director of QuidelOrtho since 2015. There are 4 older and 23 younger executives at QuidelOrtho. The oldest executive at QuidelOrtho Corporation is Mary Polan, 76, who is the Independent Director.
Over the last 21 years, insiders at QuidelOrtho have traded over $509,235,797 worth of QuidelOrtho stock and bought 304,015 units worth $10,385,234 . The most active insiders traders include Jack W Schuler, Matthew Strobeck y Group Inc.Carlyle Holdings .... On average, QuidelOrtho executives and independent directors trade stock every 16 days with the average trade being worth of $1,246,606. The most recent stock trade was executed by Group Inc.Carlyle Holdings ... on 9 August 2024, trading 74,134 units of QDEL stock currently worth $3,078,785.
QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.
QuidelOrtho executives and other stock owners filed with the SEC include: